期刊文献+

阿司匹林对胰岛瘤细胞株NIT-1细胞增殖及NF-κB表达的影响 被引量:2

Effect of aspirin on proliferation and nuclear factor kappa B p65 expression in NIT-1 insulinoma cells
原文传递
导出
摘要 目的探讨阿司匹林对胰岛瘤细胞株NIT-1细胞增殖、胰岛素分泌及NF-κB p65的影响。方法培养胰岛细胞株NIT-1细胞,经不同浓度阿司匹林处理后,采用MTT法检测细胞增殖,Hoechest33342荧光染色法观察细胞核形态和细胞凋亡变化,用放射免疫法测定胰岛素分泌和通过NF-κB p65激活-核转运试剂盒在荧光显微镜下检测NF-κB p65的表达。结果随药物浓度增加和作用时间的延长,阿司匹林对NIT-1细胞增殖的抑制作用逐渐增强,细胞培养24h时,5mmol/L阿司匹林组与对照(NC)组比较(P=0.011374),10mmol/L阿司匹林组与NC组比较(P=0.000079),差异均有统计学意义。随阿司匹林剂量的不断增加,细胞培养各时间段均出现不同的剂量-效应关系。当药物浓度在1mmol/L时,细胞培养48h后,细胞增殖明显变缓慢,胰岛素分泌水平降低,且表现出明显的时间-效应关系。随阿司匹林浓度的增加,凋亡细胞数明显增多,细胞内NF-κB p65表达显著下降。结论阿司匹林对胰岛瘤细胞株NIT-1的增殖具有抑制作用,其抑制作用随阿司匹林浓度增加,呈时间-效应和剂量-效应关系。 Objective To investigate the effect of aspirin on proliferation, insulin secretion, and nuclear factor kappa B (NF-κB) p65 protein expression in insulinoma NIT-1 cells. Methods The cultured insulinoma NIT-1 ceils were treated with aspirin in different concentrations. Effect of aspirin on proliferation of NIT-1 ceils was evaluated by MTT assay, and the morphological and apoptotic changes were observed by immunofluorescence techniques with Hoechst 33342 staining. The insulin was measured by insulin Radioimmunoassay detection Kit. Expression of NF-κB p65 was determined under a fluorescence microscope by Cellular NF-κB Translocation Kit. Results Inhibition rate of the NIT-1 cells was obviously enhanced along with the increased aspirin concentratiorL When cultured for 24 h, in the comparisons of 5mmol/L aspirin group with the control group (P = 0. 011374) and 10mmol/L aspirin group with the control group (P=0. 000079), the differences were statistically significant. Along with the increase of aspirin doses, there appeared the dose-dependent changes of NIT-1 cell proliferation and NF-κB p65 expression. When the cells cultured in aspirin at 1 mmol/L for 48 h, the cell proliferation became slow significantly, and the insulin secretion was lowered, showed a significant time-effect relationship. When the aspirin dose increased, the apoptotic cells were getting significantly more, while the expression of NF- κB p65 was getting significantly less. Conclusion Aspirin can inhibit the proliferation of pancreatic islet NIT-1 cells, and this inhibition shows time-effect and dose-effect relations with the increase of aspirin concentration.
机构地区 桂林医学院
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2012年第11期862-866,共5页 Chinese Journal of Diabetes
基金 国家自然科学基金项目资助课题(30860116) 国家自然科学基金项目资助课题(31060161) 广西科学研究与技术开发计划资助项目(0728230) 广西教育厅科研基金资助课题(院科字[2008]17号)
关键词 阿司匹林 胰岛瘤细胞 核因子ΚB 细胞凋亡 Aspirin Insuloma cell line Nuclear factor kappa B (NF-κB) p65 Apoptosis
  • 相关文献

参考文献10

  • 1Cull CA, Nell HA, Holrnan RR. Changing aspirin use in patients with type 2 diabetes in the UKPDS. Diabet Med, 2004, 21:1368-1371.
  • 2Antithrombotie Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ Med, 2002, 324:71-86.
  • 3U.S. Preventive ServicesTask Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med,2002, 136:157-160.
  • 4Antithrornbotic Trialists (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative recta-analysis of indi vidual participant data from randomised trials. Lancet, 2009, 373 : 1849-1860.
  • 5Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of coloreetal cancer. JAMA, 2005, 294:914-923.
  • 6De Berardis G, Sacco M, Strippoli GF, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ, 2009, 339:b4531.
  • 7Woods RL, Tonkin AM, Nelson MR, et al. Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes? Med J Aust, 2009, 190:614-615.
  • 8Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ, 2008, 337:a1840.
  • 9Ogawa H, Nakayama M, Marimato T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA, 2008, 300 : 2134-2141.
  • 10Chen HN, Wang DJ, Ren MY, et al. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-κB pathway. Mol Biol Rep, 2012, 39: 8231-8241.

同被引文献25

  • 1王蓓,邢邯英,李建立,褚兆苹,贾利刚,秦英.阿司匹林对宫颈癌Hela细胞凋亡及增殖的影响[J].中国老年学杂志,2014,34(9):2459-2462. 被引量:4
  • 2郑秀娟,李淞漪.阿司匹林对宫颈癌Hela细胞COX-2 mRNA表达的抑制作用[J].浙江临床医学,2007,9(11):1461-1462. 被引量:5
  • 3Song X,Hu X,LüS,et al.Incorporation of arsenic trioxide in induction therapy improves survival of patient with newly diagnosed acute promyelocytic leukaemia.Eur J Haematol,2014;93(1):54-62.
  • 4Rothwell PM,Fowkes FG,Belch JF,et al.Effect of daily aspirin on long-term risk of death due to cancer:analysis of individual patient data from randomised trials.Lancet,2011;377(9759):31-41.
  • 5Goel A,Chang DK,Ricciardiello L,et al.A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells.Clin Cancer Res,2003;9(1):383-390.
  • 6Hossain MA,Kim DH,Jang JY,et al.Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocelluar carcinoma cells in vitro and in vivo.Int J Oncol,2012;40(5):1636-1642.
  • 7Chen RH,Tian YJ.Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells.Asian Pac J Cancer Prev,2013;14(5):3041-3044.
  • 8Li G,Zhang S,Fang H,et al.Aspirin overcomes Navitoclaxresistance in hepatocellular carcinoma cells through suppression of Mcl-1.Biochem Biophys Res Commun,2013;434(4):809-814.
  • 9Pennarun B,Klleibeuker JH,Boersma-van Ek W,et al.Targeting FLIP and Mcl-1using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.J Pathol,2013;229(3):410-421.
  • 10Alarifi S,Ali D,Alkahtani S,et al.Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells.Onco Targets Ther,2013;6:75-84.doi:10.2147/OTT.S38227.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部